Pancreatic Cancer Research at TGen Gets $18 Million Infusion
How bad is pancreatic cancer? Ninety percent of people who find out they have it die within a year. And the pancreas isn't even a brand-name digestive organ, like the kidney or liver.
The ghastly statistic is one reason the gene-science gurus at TGen in Phoenix are major recipients in $74 million of gifts being distributed nationwide by the Stand Up to Cancer foundation. TGen's getting $18 million.
What's great about this foundation is the aim to put research into practice -- and make patients well -- ASAP. The research conducted by TGen with its share of the gifts will be tried out at Scottsdale Healthcare at Shea hospital.
TGen says its role will be to:
...launch a series of innovative clinical trials in advanced pancreatic cancer. These clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply.
Sounds like a plan.
Get the ICYMI: Today's Top Stories Newsletter Our daily newsletter delivers quick clicks to keep you in the know
Catch up on the day's news and stay informed with our daily digest of the most popular news, music, food and arts stories in Phoenix, delivered to your inbox Monday through Friday.